001     288993
005     20250514132959.0
024 7 _ |a 10.1002/cac2.12526
|2 doi
024 7 _ |a pmid:38487965
|2 pmid
024 7 _ |a 1000-467X
|2 ISSN
024 7 _ |a 1944-446X
|2 ISSN
024 7 _ |a 2523-3548
|2 ISSN
024 7 _ |a altmetric:160777172
|2 altmetric
037 _ _ |a DKFZ-2024-00540
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Jansana, Anna
|0 0000-0001-8504-1618
|b 0
245 _ _ |a Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study.
260 _ _ |a Hoboken, NJ
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1716466452_27470
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 May;44(5):593-597
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Auguste, Aviane
|b 1
700 1 _ |a Kvaskoff, Marina
|b 2
700 1 _ |a Fournier, Agnès
|b 3
700 1 _ |a Fontvieille, Emma
|b 4
700 1 _ |a Peruchet-Noray, Laia
|b 5
700 1 _ |a Biessy, Carine
|b 6
700 1 _ |a Cordova, Reynalda
|b 7
700 1 _ |a Nielsen Petersen, Kristina Elin
|b 8
700 1 _ |a Tjønneland, Anne
|b 9
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 10
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 11
|u dkfz
700 1 _ |a Ricceri, Fulvio
|b 12
700 1 _ |a Panico, Salvatore
|b 13
700 1 _ |a Contiero, Paolo
|b 14
700 1 _ |a Sánchez, Maria-Jose
|b 15
700 1 _ |a Castilla, Jesus
|b 16
700 1 _ |a Crous-Bou, Marta
|b 17
700 1 _ |a Heath, Alicia
|b 18
700 1 _ |a Aglago, Elom Kouassivi
|b 19
700 1 _ |a Weiderpass, Elisabete
|b 20
700 1 _ |a Gunter, Marc James
|b 21
700 1 _ |a Ferrari, Pietro
|b 22
700 1 _ |a Riboli, Elio
|b 23
700 1 _ |a Viallon, Vivian
|b 24
700 1 _ |a Freisling, Heinz
|b 25
773 _ _ |a 10.1002/cac2.12526
|g p. cac2.12526
|0 PERI:(DE-600)2922913-3
|n 5
|p 593-597
|t Cancer communications
|v 44
|y 2024
|x 1000-467X
856 4 _ |u https://inrepo02.dkfz.de/record/288993/files/Cancer%20Communications%20-%202024%20-%20Jansana%20-%20Impact%20of%20pre%E2%80%90existing%20cardiometabolic%20diseases%20on%20metastatic%20cancer%20stage%20at.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/288993/files/Cancer%20Communications%20-%202024%20-%20Jansana%20-%20Impact%20of%20pre%E2%80%90existing%20cardiometabolic%20diseases%20on%20metastatic%20cancer%20stage%20at.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:288993
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:05:11Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:05:11Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T09:05:11Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2023-05-02T09:05:11Z
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER COMMUN : 2022
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-27
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b CANCER COMMUN : 2022
|d 2023-10-27
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-10-27
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-10-27
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21